miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway
Lingqin Song(Second Affiliated Hospital of Xi'an Jiaotong University), Xi-Jing Wang(Second Affiliated Hospital of Xi'an Jiaotong University)
Cited by 54